source
- Aura Biosciences cuts 20% of staff and reshuffles C-suite to focus on ocular oncologyAura Biosciences announced it is eliminating about one-fifth of its workforce as part of a broader restructuring under its new chief executive officer, Natalie Holles, who took the helm in April.…
- WuXi AppTec Co-CEO Stresses Need for True Resilience Beyond Redundancy in Biopharma InnovationIn a recent Fierce Biotech interview, WuXi AppTec co-CEO Dr. Steve Yang discussed how the biopharma sector can build resilience as scientific challenges grow. Yang said resilience is not just abou…